Cargando…
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
Autores principales: | Boero, Silvia, Morabito, Anna, Banelli, Barbara, Cardinali, Barbara, Dozin, Beatrice, Lunardi, Gianluigi, Piccioli, Patrizia, Lastraioli, Sonia, Carosio, Roberta, Salvi, Sandra, Levaggi, Alessia, Poggio, Francesca, D’Alonzo, Alessia, Romani, Massimo, Del Mastro, Lucia, Poggi, Alessandro, Pistillo, Maria Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724068/ https://www.ncbi.nlm.nih.gov/pubmed/26801979 http://dx.doi.org/10.1186/s12967-016-0779-y |
Ejemplares similares
-
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
por: Boero, Silvia, et al.
Publicado: (2015) -
FcγRIIa and FcγRIIIa genes polymorphism in Egyptian children with primary immune thrombocytopenia
por: Zakaria, Marwa, et al.
Publicado: (2023) -
The impact of FcγRIIa and FcγRIIIa gene polymorphisms on responses to RCHOP chemotherapy in diffuse large B-cell lymphoma patients
por: ROŽMAN, SAMO, et al.
Publicado: (2016) -
Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC
por: Mao, Changchuin, et al.
Publicado: (2021) -
Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIa(R131) and FcγRIIa(H131)
por: Mimoto, F., et al.
Publicado: (2013)